The presentation by Dr. Armin Furtwaengler at the 4th Global Precision Medicine & Biomarkers Leaders Summit discusses the impending disruption in the healthcare industry due to advancements in digital health, including collaborations across various sectors. It highlights how new business models, empowered by technologies such as AI and genomic sequencing, will reshape patient care, making individuals more involved in their health management. The document emphasizes the necessity for partnerships across academia, technology, and healthcare to leverage innovative solutions and improve healthcare outcomes.